Comparative Outcomes of Budesonide MMX versus Prednisolone for Ulcerative Colitis: Results from a British Retrospective Multi-Centre Real-World Study

Comparative Outcomes of Budesonide MMX versus Prednisolone for Ulcerative Colitis: Results from a British Retrospective Multi-Centre Real-World Study

During the COVID-19 pandemic many IBD units chose Budesonide MMX (Cortiment) as the first-line treatment for flares of ulcerative colitis (UC) in outpatients for its favourable side effect profile. This retrospective study of all UC patients treated with oral steroids between 1 March 2019–30 June 20...

Full description

Bibliographic Details
Main Authors: Konstantina Rosiou, Elaine Ong Ming San, Aditi Kumar, Kim Esquivel, Saima Almas, Daniel Stokes, Tze Ng, Nishani Jayasooriya, Ian Ranasinghe, Richard Pollok, Matthew Brookes, Christian P. Selinger
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Journal of Clinical Medicine
Subjects:
ulcerative colitis
inflammatory bowel disease
prednisolone
Budesonide MMX
Cortiment
COVID-19
Online Access:https://www.mdpi.com/2077-0383/10/19/4329

Internet

https://www.mdpi.com/2077-0383/10/19/4329

Similar Items